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This study demonstrated determination of fetal gender from nucleated red
blood cells (NRBCs) in maternal blood and attempted to apply prenatal diagnosis of hemo-
philia A using BclI DNA polymorphism. Venous blood was drawn from 20 pregnant women,
and NRBCs were recovered by magnetic activated cell sorting and anti-GPA (glycophorin A)
immunostaining. After microdissector isolation of the NRBCs, primer extension preamplifi-
cation (PEP) and nested PCR of the amelogenin gene were performed to determine fetal
gender. We also performed PEP and nested PCR of BclI polymorphism to verify the validity
of prenatal diagnosis of hemophilia A. DNA amplification was achieved in 107 cells (51.9%)
and fetal gender determined with 65.0% accuracy. Unfortunately, we could not verify the
validity within the scope of this study. However, in a larger number of cases that are infor-
mative in BclI polymorphism, we will be able to identify patients affected by hemophilia A
using fetal NRBCs in maternal blood.
 






 of obtaining fetal ma-
terial for prenatal diagnosis present significant proce-
dure-related risks to both the fetus and the mother.
Many researchers have made efforts to obtain fetal
materials by noninvasive means. Among those meth-
ods, fetal cells, especially nucleated erythrocytes [nu-
cleated red blood cells (NRBCs)] in maternal periph-
eral blood, have been the focus of research during the
past 15 years.
Various immunological traits have been tried to en-
rich fetal NRBCs. We used magnetic activated cell
sorting (MACS) for CD71 (transferrin receptor) of
NRBCs. After positive MACS with anti-CD71 anti-
body, we could expect that the magnetically labeled
cell suspension eluted from the MACS column contains
NRBCs, activated lymphocytes, and macrophages. Be-
cause cells of erythroid lineage have glycophorin A
(GPA) as a cell membrane antigen, we used immuno-
staining with an anti-GPA antibody to differentiate
fetal NRBCs in cell suspension, which eluted after
MACS for CD71. It has been well established that this
combination of antigens is excellent for isolation of
nucleated erythrocytes (Bianchi et al. 1990,1992; Price
et al. 1991; Wachtel et al. 1991; Ganshirt-Ahlert et al.
1992; Reading et al. 1995). However, even after sepa-
ration with monoclonal antibodies, maternal cell con-
tamination is unavoidable. Therefore, we picked up a
single cell with a micromanipulator (Takabayashi et
al. 1995).
The problem is that NRBCs in maternal peripheral
blood are of both fetal and maternal origin (Ganshirt
et al. 1994; Slunga-Tallberg et al. 1995,1996; von
Eggeling et al. 1997; Holzgreve et al. 1998; Troeger et
al. 1999). However, despite the fact that nucleated
erythrocytes in maternal peripheral blood are of fetal
and maternal origin, many researchers have claimed
that they can diagnose various disorders using NRBCs
in maternal peripheral blood, such as hemoglobinopa-
thies (Di Naro et al. 2000), Rhesus type, and Du-
chenne muscular dystrophy (Sekizawa et al. 1996a,b).
Therefore, we focused on the possibility of diagno-
sis of hemophilia A using fetal nucleated erythrocytes
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analysis of the BclI/intron 18 and St14 VNTR poly-
morphisms is useful in carrier detection and prenatal
diagnosis of hemophilia A, and the observed heterozy-
gosity for BclI/intron 18 polymorphism was 21.0%
(Choi et al. 2000). Because it is very difficult to apply
St14 VNTR analysis in single-cell PCR, we tried BclI
polymorphism to diagnose hemophilia A.
In this study, we first tried to examine the efficacy
of a noninvasive method by using fetal NRBCs in ma-
ternal peripheral blood to determine fetal gender. Sec-
ond, we aimed to check the validity to diagnose he-





Peripheral blood samples (20 ml) were collected in EDTA
tubes from 20 healthy women with uncomplicated singleton
pregnancies (10 male, 10 female fetuses) between 10 and 22
weeks of gestation. This patient population included nine
primigravidas and 11 multigravidas referred to our antena-
tal testing unit for amniocentesis or chorionic villus sam-
pling (CVS) because of advanced maternal age and abnor-
mal triple screen results. All patients were Rh positive. The
samples were collected before amniocentesis or CVS was
performed.
 
Isolation and Enrichment of Nucleated Cells
 
The blood samples were diluted with a double volume of
PBS. Nucleated cells were isolated by density gradient cen-
trifugation using Ficoll-Paque (Pharmacia Biotech; Uppsala,




 g for 30
min. The layer of cells between plasma and Ficoll-Paque,
in which most mononucleated cells were recovered, was




 g for 10
min. After the washing procedure was repeated and the su-
pernatant decanted, the cell pellet was resuspended in PBS to
allow counting of the total number of recovered cells.
After centrifugation and resuspension of the pellet in PBS
[supplemented with 0.5% bovine serum albumin (BSA) and
2 mM EDTA], the samples were incubated for 15 min at 4C
with a 1:10 solution of monoclonal antibodies (CD 71;
Miltenyi Biotec, Bergisch Gladbach, Germany) and inacti-
vated plasma. Separation was achieved with the mini-MACS
system (Miltenyi Biotec) according to the manufacturer’s
recommendations.
 
Slide Preparation and Immunophenotyping
 
After mini-MACS separation, in theory the eluted cell sus-
pension would contain NRBCs, activated lymphocytes, and
macrophages. We tried to separate NRBCs from the remain-
ing cells using anti-GPA antibody. Therefore, we made slides
for microscopic examination by cytocentrifugation (Shan-
don Southern; Runcorn, U.K.). The slides were fixed in cold
acetone for 5 min. Anti-GPA (mouse anti-human glyco-
phorin A) monoclonal antibody (DAKO; Carpinteria, CA)
was used to identify NRBCs by 3-amino-9-ethyl-carbazole
immunostaining (DAKO). Hematoxylin counterstaining was
used for morphological characterization of the cells. Finally,
the immunophenotyped cells were classified under a light
microscope. The coordinates of GPA-positive nucleated eryth-
rocytes on the slides were recorded and the cells photo-
graphed.
 
Single-cell Isolation by Microdissector
and Fine Needle
 
Single NRBCs, recognized as red by anti-GPA immunocyto-
chemistry, were collected with a 30-G needle and microdis-
sector (Figure 1). Each NRBC was transferred to its own




l distilled water and then snap-frozen in
liquid nitrogen. Protein digestion was carried out for 2 hr at









(10 mM Tris-HCl, pH 8.3, 50 mM KCl). After complete di-
gestion, proteinase K was inactivated by heating to 94C for
2 min.
 
Amplification of DNA by Primer
Extension Preamplification
 
Primer extension preamplification (PEP) was performed as
described by Zhang et al. (1992). Briefly, the initial reaction
volume containing the digested single cell was brought to a








M totally degenerated 15-
mer primer (Operon Technologies; Alameda, CA), PCR buffer









M dNTPs, and 5 U Taq polymerase (Takara;
Tokyo, Japan). Fifty cycles were carried out in a PTC 200
thermocycler (MJ Research; Cambridge, MA). Each cycle
consisted of 1 min denaturation at 92C, 2 min annealing at
37C, heating to 55C at 0.1C/sec, and 4 min extension at
55C. After PEP, the PCR product was stored at 4C as a tem-
plate for nested PCR.
 
Nested PCR of Amelogenin Loci and BclI
Polymorphic Loci
 
We used nested PCR amplification of the amelogenin gene
on chromosomes X and Y for gender determination of the
samples (Schaaff et al. 1996). The following procedure was














nal concentrations of 10 mM Tris-HCl (pH 8.3), 50 mM




, 0.001% (w/v) gelatin, 0.2 mM of each


















)], and 1 U Taq polymerase.
Samples were heated at 94C for 5 min to ensure DNA dena-
turation, followed by 30 cycles of denaturation at 94C for
30 sec, annealing at 52C for 60 sec, and extension at 72C
for 60 sec. Final extension at 72C was allowed for 10 min.




l of amplified product was





PCR mix. This mix was the same as outer PCR except that it























 concentration was increased to 2.5 mM. The
amplification cycle of inner PCR included denaturation at
94C for 30 sec, annealing at 56C for 30 sec, and extension
at 72C for 60 sec. Final extension was performed at 72C for

































 tris borate EDTA with ethidium bromide
and visualized using an ultraviolet transilluminator. A cell
was considered to be genotypically female if one band of
323 base pairs (bp) was present and male if a band of 142
bp was also present.
BclI polymorphism (Snabes et al. 1994) was performed
for seven pregnant women. The slightly modified PCR pro-













l and final concentrations of 10 mM Tris-HCl (pH 8.3), 50








M of each dNTP, 0.25




-CTA CCT GGC TTA








-AAA GGA ATA AAT




)], and 1.25 U Taq polymerase. Samples
were heated at 92C for 3 min to ensure DNA denaturation,
followed by 20 cycles of denaturation at 92C for 30 sec, an-
nealing at 49C for 30 sec, and extension at 72C for 30 sec.





l of amplified product was transferred to a




l of fresh PCR mix. This


















)] in place of the
outer primers. After initial denaturation at 92C for 3 min,
30 cycles of amplification were carried out for inner PCR
(92C for 30 sec, 46C for 30 sec, and 72C for 30 sec for de-
naturation, annealing, and extension, respectively). Final ex-
tension was performed at 72C for 3 min. BclI (30 U) was




l aliquots were electrophoresed on a 2% agarose gel.
Results
 
The first part of this study aimed to examine the effi-
cacy of a method using fetal cells in maternal periph-
eral blood by determining fetal gender using the ame-
logenin gene from 20 pregnant women.
In total, 206 cells were obtained from peripheral
blood of 20 pregnant women. Among these, 107 cells
(51.9%) could be amplified by PEP and nested PCR of
the amelogenin gene.
In each of 20 cases, 1–25 NRBCs were screened
with the amelogenin system for gender determination
(Table 1). Gender was ascertained in each case by
karyotyping of chorionic villi or amniocytes.
In this study, we assigned the fetus as male if we
could find any single cell that showed a band corre-
sponding to the Y-chromosome allele in amelogenin
PCR. According to this rule, we correctly identified
8/10 male fetuses and 5/10 female fetuses. Combining
these results, the accuracy of gender determination in
our approach was 65.0%.
The second part of this study aimed to check the
validity of diagnosing hemophilia A by BclI polymor-
phism using fetal NRBCs in maternal blood. We se-
lected 85 NRBCs from seven pregnant women, of which
47 cells (55.3%) could be amplified by PEP/nested
PCR of BclI polymorphism. However, only one of the
seven pregnant women showed a difference between
fetus (amniotic fluid) and mother (peripheral blood)
in restriction fragment length polymorphism pattern.
That is to say, BclI polymorphism was informative in
only one pregnant woman. Because of lack of infor-
mative cases using BclI polymorphism in this study,
we could not be sure whether prenatal diagnosis of he-
mophilia A by fetal NRBCs in maternal peripheral
Figure 1 After MACS and anti-GPA
antibody immunostaining (A), single
cells can be harvested with a micro-




Nucleated erythrocytes separated from 16 pregnant 






















1 5 3 3 0 F F
2 18 3 3 0 F F
3 8 2 2 0 F F
4 10 10 10 0 F F
5 7 1 1 0 F M
6 19 8 7 1 M M
7 6 6 3 3 M M
8 9 9 0 9 M M
9 25 24 6 18 M M
10 20 2 0 2 M M
11 16 6 1 5 M M
12 17 7 5 2 M M
13 5 5 1 4 M F
14 14 8 6 2 M F
15 7 7 0 7 M F
16 2 2 0 2 M F
17 2 1 1 0 F M
18 1 1 1 0 F F
19 9 1 0 1 M F
20 6 1 0 1 M M
Total 206 107
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blood is applicable. However, in this case, in spite of a
male-bearing pregnancy, three cells showed a female-
specific band pattern in amelogenin PCR. In addition,
these three cells showed the same band pattern as ma-
ternal cells in BclI polymorphism (Figure 2). There-





Because of the rarity of fetal NRBCs in maternal pe-
ripheral blood, it has been a challenge to enrich fetal
cells from maternal peripheral blood and then analyze
them for genetic disorders.
In this study, we used CD71 antibody against the
transferrin receptor, which has been widely employed.
In addition to MACS with the anti-CD71 antibody,
we further tried to differentiate fetal NRBCs from
other cells by anti-GPA antibody and by single-cell
pick-up with a micromanipulator.
However, this study was fraught with considerable
amplification failure (48.1%). There appeared to be
several explanations for amplification failure. First,
some template degradation may have occurred during
the course of the enrichment and staining procedures
(Reading et al. 1995; Cheung et al. 1996). Second, mi-
crodissection of cells fixed on slides can induce me-
chanical DNA breakage and thus loss of amplification
from one or two alleles (Cheung et al. 1996). In these
situations, however, analysis of several cells could
avoid misdiagnosis. Third, it is probably to some ex-
tent related to cell loss during the micromanipulation,
because the final transfer of the picked cell to the PCR
tube is not under visual control. Laser-assisted mi-
cromanipulation and automatic transfer directly into
the PCR tube (Schutze and Clement-Sengewald 1994)
might circumvent cell loss and mechanical DNA break-
age. Finally, although we used PEP, it is impossible to
amplify the target sequences every time because of sig-
nificant locus-dependent variation in amplification ef-
ficiency (Sekizawa et al. 1996b).
Despite these problems, we could correctly assign
fetal gender in 13/20 (65%) pregnant women. This
result is comparable to those of previous studies
(Sekizawa et al. 1996a,b; von Eggeling et al. 1997).
Because we used heterozygous alleles (amelogenin
gene and BclI polymorphism) and whole-genome
amplification, we expected to have allelic drop-out
(ADO).
As many researchers (von Eggeling et al. 1997;
Garvin et al. 1998; Hahn et al. 1998) have observed,
ADO is more likely to occur after whole-genome
amplification. Nevertheless, Hahn et al. (1998) and
Garvin et al. (1998) have recommended examination
of multiple single cells and multiplex PCR for simulta-
neous identification using microsatellite loci known to
be informative for solving the problem of ADO. Ac-
cordingly, we performed PCR in 47 cells and per-
formed PCR for the amelogenin gene and BclI poly-
morphism sequentially to avoid ADO. Nevertheless,
only one male-bearing pregnancy was informative in
BclI polymorphism, and because of the relatively high
failure rate in amplification, we cannot report the ex-
act number of cells showing ADO.
Interestingly, three cells in this case showed a fe-
male-specific band in amelogenin PCR despite a male-
bearing pregnancy and showed the same band pattern
as that of the mother in BclI polymorphism as well.
Combining these results, we could conclude that these
three cells were of maternal origin. This finding also
gives evidence that NRBCs in maternal blood are of
both fetal and maternal origin, and it is comparable
to those of previous studies (Ganshirt et al. 1994;
Slunga-Tallberg et al. 1995,1996; von Eggeling et al.
1997; Holzgreve et al. 1998; Troeger et al. 1999).
It was not possible within the scope of this study
to obtain large-scale results from BclI polymorphism,
and therefore, because of the lack of informative
cases, we could not demonstrate the validity of pre-
natal diagnosis of hemophilia A in our approach.
However, with a larger number of cases that are in-
formative in BclI polymorphism, we could identify
patients affected by hemophilia A using fetal NRBCs
in maternal blood.
In summary, our data demonstrate that our experi-
mental design is valid and that if we apply our ap-
proach to more cases that are informative in BclI poly-
morphism, it will be possible to use fetal NRBCs in
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Figure 2 Agarose gel electrophoresis of BclI polymorphism results
from a male fetus. Three cells (Lanes 3–5) of five show the same
pattern as the mother (Bl), despite coming from male fetuses (Am).
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